Publications by authors named "F Cappuzzo"

Claim this Profile
C
Crizotinib in Patients With -Positive NSCLC With or Without Brain Metastases: Post Hoc Analysis of Phase II METROS Trial.
Lorenza Landi, Rita Chiari, Marcello Tiseo, Giulio Metro, Filippo de Marinis, Federico Cappuzzo

JTO Clin Res Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations.
Tianshi Lu, Habib Hamidi, Mark A Socinski, Martin Reck, Federico Cappuzzo

Nat Commun· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DESTINY of Immunotherapy in Patients With Mutant Lung Cancer: Case Report.
Lorenza Landi, Francesca Fusco, Enrico Melis, Simonetta Buglioni, Paolo Visca, Federico Cappuzzo

JTO Clin Res Rep· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase II, multicenter, open-label, single-arm study of berzosertib plus topotecan in patients with relapsed platinum-resistant small-cell lung cancer (DDRiver SCLC 250).
A Navarro, A Thomas, Y Cheng, Y Chen, N Reguart, F Cappuzzo

ESMO Open· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploratory Analyses of Patient Preferences for Atezolizumab Subcutaneous Versus Intravenous from the IMscin002 Study in Patients with Non-Small Cell Lung Cancer.
Margarita Majem, Busyamas Chewaskulyong, Zanete Zvirbule, Ki Hyeong Lee, Ernesto Korbenfeld, Federico Cappuzzo

Oncol Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis